Log in

NASDAQ:CHAC - Chardan Healthcare Acquisition Stock Price, Forecast & News

+0.49 (+6.13 %)
(As of 12/8/2019 03:23 AM ET)
Today's Range
Now: $8.49
50-Day Range
MA: $9.96
52-Week Range
Now: $8.49
Volume3,755 shs
Average Volume25,363 shs
Market Capitalization$74.29 million
P/E RatioN/A
Dividend YieldN/A
Chardan Healthcare Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was founded in 2017 and is based in New York, New York.

Industry, Sector and Symbol

Industry Conglomerates
Current SymbolNASDAQ:CHAC



Sales & Book Value

Annual SalesN/A



Market Cap$74.29 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CHAC News and Ratings via Email

Sign-up to receive the latest news and ratings for CHAC and its competitors with MarketBeat's FREE daily newsletter.

Chardan Healthcare Acquisition (NASDAQ:CHAC) Frequently Asked Questions

What is Chardan Healthcare Acquisition's stock symbol?

Chardan Healthcare Acquisition trades on the NASDAQ under the ticker symbol "CHAC."

What price target have analysts set for CHAC?

1 equities research analysts have issued twelve-month target prices for Chardan Healthcare Acquisition's stock. Their forecasts range from $28.00 to $28.00. On average, they expect Chardan Healthcare Acquisition's share price to reach $28.00 in the next twelve months. This suggests a possible upside of 229.8% from the stock's current price. View Analyst Price Targets for Chardan Healthcare Acquisition.

What is the consensus analysts' recommendation for Chardan Healthcare Acquisition?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chardan Healthcare Acquisition in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chardan Healthcare Acquisition.

Has Chardan Healthcare Acquisition been receiving favorable news coverage?

News articles about CHAC stock have trended somewhat positive recently, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chardan Healthcare Acquisition earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the stock's share price in the next few days. View News Stories for Chardan Healthcare Acquisition.

Who are some of Chardan Healthcare Acquisition's key competitors?

Who are Chardan Healthcare Acquisition's key executives?

Chardan Healthcare Acquisition's management team includes the folowing people:
  • Dr. Gbolahan Amusa C.F.A., M.D., CFA, Exec. Chairman (Age 45)
  • Mr. Jonas Sven Magnus Grossman, Pres, CEO & Director (Age 45)
  • Mr. George B. Kaufman B.A., CFO, Head of Strategy & Director (Age 44)

How do I buy shares of Chardan Healthcare Acquisition?

Shares of CHAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chardan Healthcare Acquisition's stock price today?

One share of CHAC stock can currently be purchased for approximately $8.49.

How big of a company is Chardan Healthcare Acquisition?

Chardan Healthcare Acquisition has a market capitalization of $74.29 million. View Additional Information About Chardan Healthcare Acquisition.

How can I contact Chardan Healthcare Acquisition?

The company can be reached via phone at 646-229-7549.

MarketBeat Community Rating for Chardan Healthcare Acquisition (NASDAQ CHAC)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  2 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Chardan Healthcare Acquisition and other stocks. Vote "Outperform" if you believe CHAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel